News and Events

2017 Future Events:

AACC

San Diego, CA - July 30–August 3

TIAFT/SOFT

Boca Raton, FL - September 10-15 --- SOFT Abstract

IATDMCT

Kyoto, Japan - September 24-27

AAVLD (Veterinary)

San Diego, CA - October 12-18

June 2017

ASM/ICAAC - Voriconazole

New Orleans, LA - June 1-5

June 2017

EuroMedlab

Athens, Greece - June 11-15

May 2017

FDA de novo granted for the ARK Voriconazole II Assay.

December 2016

AES

Houston, TX - December 02-06

October 2016

SOFT

Dallas, TX - October 16-21

August 2016

ARK Diagnostics received 510(k) clearance from FDA for the ARK Oxcarbazepine Metabolite Assay.

August 2016

TIAFT

Brisbane, Australia - August 28-September 1

July 2016

AACC

Philadelphia, Pennsylvania - July 31-August 4

AIDS

Durban, South Africa - July 17-22

February 2016

AAFS - American Academy of Forensic Sciences

Las Vegas, Nevada - February 22-27

December 2015

American Epilepsy Society

Philadelphia, PA - December 4-8

October 2015

SOFT-TOX Meeting

Atlanta, GA - October 18-23, 2015

October 2015

IATDMCT

Rotterdam, Netherlands - October 11-15, 2015

August 2015

TIAFT

Florence, Italy, August 30-September 4, 2015

July 2015

AACC

Atlanta, GA - July 26-30, 2015

June 2015

Euromedlab

Paris, France - June 21-25, 2015

December 2014

American Epilepsy Society

Dec 6-8, Seattle,WA

October 2014

Society of Forensic Toxicologists, Inc. Meeting

Oct 20-23, Grand Rapid, MI

July 2014

AACC

July 27-31, Chicago,IL

December 2013

American Epilepsy Society

Dec 7-9, Washington, DC

October 2013

Society of Forensic Toxicologists, Inc. Meeting

Oct 29-31, Orlando, FL

September 2013

IATDMCT

Sept 22-26, Salt Lake City, UT

August 2013

AACC

July 28-Aug 1, Houston, TX

August 2012

ARK Diagnostics, Inc. relocated its product development and manufacturing operations to a new facility in Fremont, California. ARK has re-established its California Manufacturing License and ISO 13485:2003 CMDCAS certification.

October 2011

ARK Diagnostics received 510(k) clearance from FDA for the ARK Methotrexate Assay.

October 2011

IATDMCT

October 2-6 2011, Stuttgart, Germany

July 2011

AACC

July 26-28 2011, Atlanta, GA

April 2011

AACC-TDM Division Meeting

Chicago, IL

December 2010

ARK Immunoassays for Antiepileptic Drugs: Gabapentin, Lamotrigine, Levetiracetam, Topiramate, Zonisamide

American Epilepsy Society, 64th Annual Meeting

December 3-7, San Antonio, TX

November 2010

ARK Diagnostics received 510(k) clearance from FDA for the ARK Gabapentin Assay.

October 2010

ARK achieved re-certification to ISO13485:2003 (FM523575)

ARK Diagnostics received 510(k) clearance from FDA for the ARK Lamotrigine Assay.

December 2009

ARK Diagnostics received 510(k) clearance from FDA for the ARK Zonisamide Assay.

November 2009

ARK Diagnostics received 510(k) clearance from FDA for the ARK Levetiracetam Assay.

October 2009

11th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology

ARK Homogeneous Enzyme Immunoassays for the Newer Antiepileptic Drugs
October 3-8, Montréal

July 2009

ARK introduces three assays at the 2009 Annual Meeting of the American Association of Clinical Chemistry. ARK Topiramate Assay is FDA cleared. FDA clearance is pending for ARK Levetiracetam Assay and ARK Zonisamide Assay.

2009 AACC (American Association for Clinical Chemistry) Annual Meeting
July 18 - 23, Chicago

July 2009

2009 AACC (American Association for Clinical Chemistry) Annual Meeting
July 18 - 23, Chicago

ARK Topiramate Assay on Roche/Hitachi 917 System

Validation of New Immunoassay for Quantification of Topiramate

April 2009

ARK Diagnostics received 510(k) clearance from FDA for the ARK Topiramate Assay.

July 2008

2008 AACC (American Association for Clinical Chemistry) Annual Meeting
July 27 - 31, Washington, DC

Therapeutic Drug Monitoring Immunoassay for Efavirenz

November 2007

ARK achieved ISO 13485:2003 certification (certificate number FM 523575). ARK is committed to providing quality products to its customers and this certification is evidence of ARK's commitment and its established quality management system.

June 2007

ARK achieved a Device Manufacturing License from the State of California.

April 16-18, 2007

8th International Workshop on Clinical Pharmacology of HIV Therapy
Budapest, Hungary

The ARK APV-Test™:Rapid Automated Immunoassay for Amprenavir in Human Plasma

September 27, 2006

46th Interscience Conference on Antimicrobial Agents and Chemotherapy
San Francisco, California

Rapid Automated Immunoassay for Therapeutic Drug Monitoring of Lopinavir: Method Evaluation and Comparison to LC-MS-MS

August 2006

XVI International AIDS Conference
Toronto, Canada

The ARK EFV-Test™: A Rapid, Automated Immunoassay for Therapeutic Drug Monitoring of Efavirenz

July 16, 2006

ARK Diagnostics, Inc. joined 20th Annual AIDS Walk San Francisco.

View certificate